Oral pH

1: Choi JE, Loke C, Waddell JN, Lyons KM, Kieser JA, Farella M. Continuous

measurement of intra-oral pH and temperature: development, validation of an

appliance and a pilot study. J Oral Rehabil. 2015 Aug;42(8):563-70. doi:

10.1111/joor.12294. Epub 2015 Mar 21. PubMed PMID: 25809398.

2: Urban EH, Mannan RW. The potential role of oral pH in the persistence of

Trichomonas gallinae in Cooper's Hawks (Accipiter cooperii). J Wildl Dis. 2014

Jan;50(1):50-5. doi: 10.7589/2012-12-322. Epub 2013 Oct 25. PubMed PMID:

24171574.

3: Lindquist B, Lingström P, Fändriks L, Birkhed D. Influence of five

neutralizing products on intra-oral pH after rinsing with simulated gastric acid.

Eur J Oral Sci. 2011 Aug;119(4):301-4. doi: 10.1111/j.1600-0722.2011.00841.x.

PubMed PMID: 21726291.

4: Davidovich E, Aframian DJ, Shapira J, Peretz B. A comparison of the

sialochemistry, oral pH, and oral health status of Down syndrome children to

healthy children. Int J Paediatr Dent. 2010 Jul;20(4):235-41. doi:

10.1111/j.1365-263X.2010.01045.x. PubMed PMID: 20536584.

5: Gross V. Oral pH-modified release budesonide for treatment of inflammatory

bowel disease, collagenous and lymphocytic colitis. Expert Opin Pharmacother.

2008 May;9(7):1257-65. doi: 10.1517/14656566.9.7.1257. Review. PubMed PMID:

18422482.

6: Viswanath L, Bhanumathi G, Reddy BK, Prabhakaran PS. Oral pH changes due to

salivary gland irradiation during radiation therapy of oral and head and neck

cancer. Indian J Dent Res. 2004 Oct-Dec;15(4):137-8. PubMed PMID: 16035642.

7: Andus T, Gross V, Caesar I, Schulz HJ, Lochs H, Strohm WD, Gierend M, Weber A,

Ewe K, Schölmerich J; German/Austrian Budesonide Study Group. Replacement of

conventional glucocorticoids by oral pH-modified release budesonide in active and

inactive Crohn's disease: results of an open, prospective, multicenter trial. Dig

Dis Sci. 2003 Feb;48(2):373-8. PubMed PMID: 12643618.

8: Moazzez R, Smith BG, Bartlett DW. Oral pH and drinking habit during ingestion

of a carbonated drink in a group of adolescents with dental erosion. J Dent. 2000

Aug;28(6):395-7. PubMed PMID: 10856803.

9: Selimoglu MA, Selimoglu E, Kurt A. Nasal mucociliary clearance and nasal and

oral pH in patients with insulin-dependent diabetes. Ear Nose Throat J. 1999

Aug;78(8):585-8, 590. PubMed PMID: 10485152.

10: Gross V, Andus T, Ecker KW, Raedler A, Loeschke K, Plauth M, Rasenack J,

Weber A, Gierend M, Ewe K, Schölmerich J. Low dose oral pH modified release

budesonide for maintenance of steroid induced remission in Crohn's disease. The

Budesonide Study Group. Gut. 1998 Apr;42(4):493-6. PubMed PMID: 9616309; PubMed

Central PMCID: PMC1727061.

11: Caesar I, Gross V, Roth M, Andus T, Schmidt C, Raedsch R, Weber A, Gierend M,

Ewe K, Schölmerich J. Treatment of active and postactive ileal and colonic

Crohn's disease with oral pH-modified-release budesonide. German Budesonide Study

Group. Hepatogastroenterology. 1997 Mar-Apr;44(14):445-51. PubMed PMID: 9164517.

12: Gross V, Andus T, Caesar I, Bischoff SC, Lochs H, Tromm A, Schulz HJ, Bär U,

Weber A, Gierend M, Ewe K, Schölmerich J. Oral pH-modified release budesonide

versus 6-methylprednisolone in active Crohn's disease. German/Austrian Budesonide

Study Group. Eur J Gastroenterol Hepatol. 1996 Sep;8(9):905-9. PubMed PMID:

8889459.

13: Caesar I, Gross V, Roth M, Andus T, Schmidt C, Raedsch R, Weber A, Gierend M,

Ewe K, Schölmerich J. Treatment of active Crohn's ileocolitis with oral

pH-modified budesonide. Germany Budesonide Study Group. Z Gastroenterol. 1995

May;33(5):247-50. PubMed PMID: 7610691.

14: Kozlowski LT, Kleiman RM. Effects of oral pH on cigarette smoking. Pharmacol

Biochem Behav. 1978 Oct;9(4):477-80. PubMed PMID: 32551.

15: Laudenbach P, Boumaza M, El-Nabbout S, Khanh-Trinh. [Measurement of oral pH,

a clinical test in current practice. Diagnostic significance]. Actual

Odontostomatol (Paris). 1974 Dec;(108):715-25. French. PubMed PMID: 4466337.

16: Mühlemann HR. Oral pH- and fluoride ion telemetry. Annu Meet Am Inst Oral

Biol. 1969:121-33. PubMed PMID: 5261351.

17: Persia V, Luridiana N. [Topical drug therapy of pathologic processes in the

mouth complicated by changes in the oral pH]. Riv Ital Stomatol. 1968

Jan;23(1):103-16. Italian. PubMed PMID: 5240037.